Targeted scan detects hidden multiple myeloma missed by standard imaging
A targeted immunoPET scan detected active multiple myeloma that standard PET/CT scans and blood tests missed, a finding that could help doctors more accurately map disease, guide treatment decisions and confirm whether cancer remains after therapy. The phase 2 clinical trial was led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
